DK134317B - I det væsentlige isomer ren N-substitueret beta-amino-alfa-benzylacrylonitrilforbindelse til anvendelse som mellemprodukt og fremgangsmåde til fremstilling af en sådan forbindelse. - Google Patents

I det væsentlige isomer ren N-substitueret beta-amino-alfa-benzylacrylonitrilforbindelse til anvendelse som mellemprodukt og fremgangsmåde til fremstilling af en sådan forbindelse.

Info

Publication number
DK134317B
DK134317B DK107770AA DK107770A DK134317B DK 134317 B DK134317 B DK 134317B DK 107770A A DK107770A A DK 107770AA DK 107770 A DK107770 A DK 107770A DK 134317 B DK134317 B DK 134317B
Authority
DK
Denmark
Prior art keywords
compound
benzylacrylonitrile
alpha
amino
preparation
Prior art date
Application number
DK107770AA
Other languages
English (en)
Other versions
DK134317C (da
Inventor
Ronald Morton Cresswell
John William Mentha
Russell Seaman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to DK90572A priority Critical patent/DK143158C/da
Priority to DK90672A priority patent/DK143026C/da
Priority to DK282776A priority patent/DK138451B/da
Priority to DK282876A priority patent/DK137453B/da
Priority to DK282976A priority patent/DK138452B/da
Publication of DK134317B publication Critical patent/DK134317B/da
Application granted granted Critical
Publication of DK134317C publication Critical patent/DK134317C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
DK107770AA 1969-03-06 1970-03-04 I det væsentlige isomer ren N-substitueret beta-amino-alfa-benzylacrylonitrilforbindelse til anvendelse som mellemprodukt og fremgangsmåde til fremstilling af en sådan forbindelse. DK134317B (da)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DK90572A DK143158C (da) 1969-03-06 1972-02-28 Fremgangsmaade til fremstilling af i det vaesentlige isomer rene beta-anilino-alfa-benzylacrylonitrilforbindelser
DK90672A DK143026C (da) 1970-03-04 1972-02-28 Fremgangsmaade til fremstilling af i det vaesentlige isomer rene beta-morpholino-alfa-benzylacrylonitrilforbindelser
DK282776A DK138451B (da) 1969-03-06 1976-06-23 Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK282876A DK137453B (da) 1969-03-06 1976-06-23 Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK282976A DK138452B (da) 1969-03-06 1976-06-23 Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1190969 1969-03-06
GB30247/69A GB1261455A (en) 1969-03-06 1969-03-06 Improvements in or relating to substituted acrylonitriles
GB2517169 1969-05-16
GB3024769 1969-06-13

Publications (2)

Publication Number Publication Date
DK134317B true DK134317B (da) 1976-10-18
DK134317C DK134317C (da) 1977-03-21

Family

ID=27448120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK107770AA DK134317B (da) 1969-03-06 1970-03-04 I det væsentlige isomer ren N-substitueret beta-amino-alfa-benzylacrylonitrilforbindelse til anvendelse som mellemprodukt og fremgangsmåde til fremstilling af en sådan forbindelse.

Country Status (18)

Country Link
US (1) US3697512A (da)
JP (3) JPS519747B1 (da)
BE (1) BE746846A (da)
CH (3) CH574399A5 (da)
CY (1) CY695A (da)
DE (2) DE2010166C3 (da)
DK (1) DK134317B (da)
FI (1) FI53969C (da)
FR (1) FR2036674A5 (da)
GB (1) GB1261455A (da)
HU (1) HU162316B (da)
IE (1) IE34044B1 (da)
IL (1) IL34006A (da)
IT (1) IT1008514B (da)
LU (1) LU60471A1 (da)
NL (1) NL171579C (da)
NO (1) NO136148C (da)
SE (6) SE400555B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300939A (en) * 1963-10-17 1967-01-31 Dur O Wal National Inc Combination adjustable tie and joint reinforcement for wall constructions
US3855265A (en) * 1969-03-06 1974-12-17 Burroughs Wellcome Co 5-benzyl pyrimidines intermediates therefore, and method
US3852276A (en) * 1969-03-06 1974-12-03 Burroughs Wellcome Co 5-benzyl pyrimidines intermediate therefore, and method
US4052553A (en) * 1969-03-06 1977-10-04 Burroughs Wellcome Co. 5-benzyl pyrimidines intermediates therefore, and method
DE2051871A1 (en) * 1969-05-16 1971-11-18 The Wellcome Foundation Ltd., London Beta-amino-alpha-aryloxymethylacrylonitrile - and 2,4-diamino-5-benzylpyrimidine derivs. useful as antibacterial agents
BR6915082D0 (pt) 1969-05-16 1973-03-08 Wellcome Found Processo de preparacao de benzil-pirimidinas
GB1407971A (en) * 1971-04-16 1975-10-01 Wellcome Found 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
JPS5481278A (en) * 1977-10-18 1979-06-28 Wellcome Found Manufacture of triiseccaminomethane
CH644111A5 (de) * 1981-05-15 1984-07-13 Siegfried Ag Verfahren zur herstellung eines substituierten pyrimidins.
FI65991C (fi) * 1981-05-28 1984-08-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt vaerdefull 5((3,4,5-trimetoxifenyl)metyl)-2,4-pyrimidindiamin
JPS5921346U (ja) * 1982-08-02 1984-02-09 清水建設株式会社 耐火被覆吹付け装置
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
CN1930135B (zh) * 2004-03-05 2011-12-28 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3拮抗剂的二氨基嘧啶
FR2929239B1 (fr) † 2008-03-31 2010-04-16 Aker Yards Sa Navire pourvu de moyens de recuperation d'energie thermique et procede correspondant
CN101575303B (zh) * 2008-05-05 2012-07-18 华东理工大学 一种3-苯胺基-2-(3,4,5-三甲氧基苄基)丙烯腈的制备方法
CN101328138B (zh) * 2008-08-04 2013-09-18 寿光富康制药有限公司 甲氧苄啶的制备方法
AR090100A1 (es) * 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
CN105294574B (zh) * 2015-11-25 2018-06-29 湖南湘易康制药有限公司 一种甲氧苄啶的合成方法
CN112480012A (zh) * 2020-12-30 2021-03-12 寿光富康制药有限公司 一种5-[(3,4,5-三甲氧基苯基)-甲基]-2,4-嘧啶二胺的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
NL122146C (da) * 1960-09-02
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
DE1620729A1 (de) * 1965-07-08 1970-08-20 Wellcome Found Verfahren zur Herstellung von substituierten Benzylpyrimidinen
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis

Also Published As

Publication number Publication date
JPS511716B1 (da) 1976-01-20
IE34044B1 (en) 1975-01-08
DE2066039B2 (de) 1979-01-11
IL34006A (en) 1972-02-29
LU60471A1 (da) 1970-09-11
DK134317C (da) 1977-03-21
DE2010166B2 (de) 1978-04-27
SE409708B (sv) 1979-09-03
HU162316B (da) 1973-01-29
DE2010166A1 (de) 1970-09-17
SE408551B (sv) 1979-06-18
SE7710288L (sv) 1977-09-14
CH574399A5 (da) 1976-04-15
CH645884A5 (de) 1984-10-31
SE409031B (sv) 1979-07-23
NO136148C (no) 1977-07-27
CH580082A5 (de) 1976-09-30
DE2010166C3 (de) 1987-01-22
CY695A (en) 1973-08-10
JPS519747B1 (da) 1976-03-30
US3697512A (en) 1972-10-10
BE746846A (fr) 1970-09-04
FR2036674A5 (da) 1970-12-24
FI53969C (fi) 1978-09-11
NO136148B (no) 1977-04-18
NL171579C (nl) 1983-04-18
GB1261455A (en) 1972-01-26
IT1008514B (it) 1976-11-30
NL7003240A (da) 1970-09-08
FI53969B (fi) 1978-05-31
JPS5245704B1 (da) 1977-11-17
IE34044L (en) 1970-09-06
SE409030B (sv) 1979-07-23
SE400555B (sv) 1978-04-03
SE399427B (sv) 1978-02-13

Similar Documents

Publication Publication Date Title
DK134317B (da) I det væsentlige isomer ren N-substitueret beta-amino-alfa-benzylacrylonitrilforbindelse til anvendelse som mellemprodukt og fremgangsmåde til fremstilling af en sådan forbindelse.
DK119607B (da) Fremgangsmåde til fremstilling af rent isophoron.
DK112306B (da) Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater.
DK139674B (da) Fremgangsmåde til fremstilling af 6-metylen-5-oxytetracyklin-hydroklorid.
DK133781B (da) Analogifremgangsmåde til fremstilling af N-substituerede 3-hydroxy-9-azamorfinanforbindelser.
DK132121C (da) Fremgangsmade til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion
DK102795C (da) Fremgangsmåde til fremstilling af 1,2,3,4,4a,5,12,12a-octahydronaphthacenforbindelser.
DK143158C (da) Fremgangsmaade til fremstilling af i det vaesentlige isomer rene beta-anilino-alfa-benzylacrylonitrilforbindelser
DK143026C (da) Fremgangsmaade til fremstilling af i det vaesentlige isomer rene beta-morpholino-alfa-benzylacrylonitrilforbindelser
DK136032B (da) Fremgangsmåde til fremstilling af benzamidforbindelser.
DK126045B (da) Fremgangsmåde til fremstilling af 1-(5-nitrothiazolyl-2)-2-oxo-tetrahydroimidazol.
DK104302C (da) Fremgangsmåde til fremstilling af 4-fluor-3,20-diketo-Δ<4>-21-brompregnener.
DK131669B (da) Fremgangsmåde til fremstilling af bicyclo/2,2,2/oct-2-ener.
DK101181C (da) Fremgangsmåde til fremstilling af bis-kvaternære forbindelser.
DK102352C (da) Fremgangsmåde til fremstilling af bis-kvaternære forbindelser.
DK101644C (da) Fremgangsmåde til fremstilling af α-alkyl-β-(3,4-dihydroxyphenyl)-alanin-forbindelser.
DK115990B (da) Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller -1,4,6-androstatrien-forbindelser.
DK95989C (da) Fremgangsmåde til fremstilling af cykloheksanon.
DK90603C (da) Fremgangsmåde til fremstilling af addukter mellem methanol og tetracyclinforbindelser.
DK95937C (da) Fremgangsmåde til fremstilling af stofskifteisomert 2,3-epoxy-1,4,5,6,7,8,8-heptachlor-2,3,3a,4,7,7a-hexahydro-4,7-methano-inden.
DK96695C (da) Fremgangsmåde til fremstilling af 1α,11α-epoxy-3,5,14,19-tetrahydroxy-20(22)-cardenolid.
DK95934C (da) Fremgangsmåde til fremstilling af thiocolchicinderivater.
DK95130C (da) Fremgangsmåde til fremstilling af thiocolchicinderivater.
DK92352C (da) Fremgangsmåde til fremstilling af 21,21,21-trihalogen-20-hydroksypregnanforbindelser.
DK96787C (da) Fremgangsmåde til fremstilling af 2,4,6-trioxo-piperidinforbindelser.

Legal Events

Date Code Title Description
PUP Patent expired